Outlook
Outlook
Elekta’s strategy provides the framework for our pursuit of profitable growth in a sustainable way and is quantified in the financial outlook.
Q1 2025/26
We expect normal seasonal development with low sales volumes as well as negative FX-effects.
Full year 2025/26
Despite present market conditions and current political
and macro-economic visibility, net sales are expected to
grow year-over-year.
Midterm targets
Gross and EBIT margins to expand, driven by price increases, product launches and volumes, resulting in a stepwise improvement towards our midterm targets to move the gross margin to prepandemic levels and an EBIT margin of 14% and higher year.
Dividend policy
Elekta’s goal is to provide shareholders with a favorable return and value growth. The policy is to distribute at least 50 percent of profit for the year in the form of dividend, repurchase of shares or comparable measures. A dividend decision is based on Elekta’s financial position, earnings trend, growth potential and investment requirements.
Dividend 2024/25
For 2024/25 the proposed dividend amounts to 2.40 SEK/share, which corresponds to 78% of the adjusted net income.
Strategic milestones
Availability of care
In the second quarter of 2024/25, Elekta achieved our target of providing access to treatment via Elekta’s installed base of linacs (baseline 2019/20) to 300 million people in underserved markets.
Elevation of care
Online adaptive treatments are driven by Elekta Unity as the MR-Linac can adapt the treatment plan in real time to changing tumor and surrounding tissue anatomy.
During 2023/24, 100 percent of Unity treatments are adapted, of which around 60 percent are adapt to shape and around 40 percent adapt to position. More than 50 percent of Unity treatments are stereotactic body radiotherapy (hypofractionation).
Participation of care
Through the Kaiku app, patients can interact with their clinicians, who get access to the patients and their symptom feedback and will react to the patients
well-being, if necessary. A positive experience for the patient and efficient problem solving for the clinicians.
